TrialDiabetologia2011

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

E Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.